Y Intercept (Hong Kong) LTD Royalty Pharma PLC Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 150,072 shares of RPRX stock, worth $5.69 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
150,072
Previous 7,649
1861.98%
Holding current value
$5.69 Million
Previous $238,000
2171.85%
% of portfolio
0.14%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding RPRX
# of Institutions
494Shares Held
283MCall Options Held
2.51MPut Options Held
940K-
Morgan Stanley New York, NY41MShares$1.56 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.39 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$873 Million0.01% of portfolio
-
Baillie Gifford & CO18MShares$683 Million0.51% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$461 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...